O'Neill M J, Weissleder R, Gervais D A, Hahn P F, Mueller P R
Department of Radiology, Massachusetts General Hospital, White 270, 55 Fruit St., Boston, MA 02114, USA.
AJR Am J Roentgenol. 2001 Sep;177(3):615-8. doi: 10.2214/ajr.177.3.1770615.
We present a treatment for recurrent, symptomatic ascites in patients with malignant disease. This report summarizes our experience with percutaneous tunneled peritoneal catheters in 24 patients.
Of the 40 consecutive patients who presented with at least four therapeutic paracenteses in a 4-week period, 24 patients underwent the percutaneous tunneled procedure. All had malignant ascites.
All 24 patients had successful insertion of a permanent tunneled peritoneal drainage catheter. Eighteen were outpatients and six were inpatients. All patients were relieved of their clinical symptoms, including abdominal distention and dyspnea, and were relieved of lower extremity discomfort. The mean life span after catheter placement was 7.2 weeks. Twenty (83%) of the 24 patients were treated at home with their catheters in place. Three patients experienced minor complications from bacterial peritonitis, which responded to antibiotics. One patient had to have his catheter removed.
Percutaneous placement of specialized tunneled catheters appears to be a viable and safe technique in patients who have symptomatic ascites that require frequent therapeutic paracentesis for relief of symptoms.
我们介绍一种针对恶性疾病患者复发性症状性腹水的治疗方法。本报告总结了我们对24例患者进行经皮隧道式腹膜导管置入术的经验。
在连续40例在4周内至少接受4次治疗性腹腔穿刺术的患者中,24例接受了经皮隧道式手术。所有患者均为恶性腹水。
24例患者均成功置入永久性隧道式腹膜引流导管。18例为门诊患者,6例为住院患者。所有患者的临床症状均得到缓解,包括腹胀和呼吸困难,下肢不适也得到缓解。导管置入后的平均生存期为7.2周。24例患者中有20例(83%)在家中留置导管接受治疗。3例患者发生细菌性腹膜炎轻微并发症,对抗生素治疗有效。1例患者不得不拔除导管。
对于有症状性腹水且需要频繁进行治疗性腹腔穿刺术以缓解症状的患者,经皮置入专门的隧道式导管似乎是一种可行且安全的技术。